Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,289,304 | 4,289,304 | 0 | $82.23M | $67.34M | 54.50% | -$14.88M |
| Alumis Inc | 2,787,398 | 2,787,398 | 0 | $21.91M | $17.11M | 13.85% | -$4.79M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 539,194 | 489,194 | -50,000 | $18.55M | $16.24M | 13.14% | -$2.32M |
| Acelyrin Inc | 3,806,410 | 3,806,410 | 0 | $11.95M | $9.40M | 7.61% | -$2.55M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $16.20M | $6.04M | 4.89% | -$10.16M |
| Lyell Immunopharma, Inc.(LYEL) | 7,102,190 | 7,102,190 | 0 | $4.55M | $3.82M | 3.09% | -$724.4K |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,519,971 | 1,198,975 | -320,996 | $15.32M | $3.60M | 2.91% | -$11.72M |